QUT has a solid record of success in solving problems for industry and the community and is therefore a diverse source of research, novel intellectual property, proprietary expertise, and innovative methodologies. Below are links to technologies currently managed by bluebox:
- Osteoarthritis therapeutic (pdf)
- Pathogen resistant banana (pdf)
- Podiatry training sets (pdf)
- Shade tolerant solar cells (pdf)
- SNP genotyping (pdf)
Further, a key strategy in the management of QUT's intellectual capital is the creation of new start-up companies. bluebox manages these activities via its guidance in identification and sourcing of investment, company/project management and board participation.
Intellectual property developed at QUT has been integral in the creation of many companies, six of which are highlighted below:
- Tissue Therapies Ltd
, with key technologies in novel growth factors and autologous cell therapies. - ImpediMed Ltd , a medical device company focusing on bioimpedance.
- Farmacule Bioindustries Pty Ltd , which is a molecular farming company.
- Evogenix Ltd provides advanced technologies to provide powerful new antibody therapeutics for world markets.
- AdAlta Pty Ltd , which is using a platform-technology approach to develop novel antibody and peptide-based therapeutics against select targets.
- Rail Innovation Australia Pty Ltd ,
a spin-off company created from the Cooperative Research Centre for Railway Engineering and Technologies (Rail CRC).
DISCLAIMER: Content on this website is for information purposes only. It does not constitute nor is it intended to constitute the provision of financial product advice. You must conduct your own due diligence on any companies / technologies before making an investment. Please read our full disclaimer.
